NHLBI GO-ESP: Women's Health Initiative Exome Sequencing Project (WHI) - WHISP

Request Access

Anthropometry (4)

esp_bmi_baseline - BASELINE BODY MASS INDEX (phv00161375.v3.p3)
esp_height_baseline - BASELINE HEIGHT IN CM (phv00165271.v2.p3)
esp_waist_baseline - BASELINE WAIST CIRCUMFERENCE (phv00165269.v2.p3)
esp_weight_baseline - BASELINE WEIGHT IN KG (phv00165268.v2.p3)

Biomarkers (21)

esp_afib_baseline - BASELINE ATRIAL FIBRILLATION (phv00165282.v2.p3)
esp_afib_during_followup - INCIDENT ATRIAL FIBRILLATION DURING STUDY FOLLOWUP (phv00165283.v2.p3)
esp_aflut_at_ekg - ARTERIAL FLUTTER (phv00165299.v2.p3)
esp_avblock2_at_ekg - SECOND DEGREE AV BLOCK (phv00165301.v2.p3)
esp_avblock3_at_ekg - THIRD DEGREE AV BLOCK (phv00165302.v2.p3)
esp_dbp_baseline - BASELINE DIASTOLIC BLOOD PRESSURE (phv00161398.v3.p3)
esp_ekg_hr - HEART RATE (phv00165298.v2.p3)
esp_ekg_pr - PR INTERVAL (phv00165297.v2.p3)
esp_ekg_qrs - QRS INTERVAL (phv00165295.v2.p3)
esp_ekg_qt - QT INTERVAL (phv00165296.v2.p3)
esp_fastinsulin_baseline - BASELINE INSULIN RIA METHOD (phv00165310.v2.p3)
esp_hdl_baseline - BASELINE HDL (phv00165309.v2.p3)
esp_hematocrit - HEMATOCRIT (phv00161383.v3.p3)
esp_hemoglobin - HEMOGLOBIN (phv00161381.v3.p3)
esp_ldl_baseline - BASELINE LDL (phv00161377.v3.p3)
esp_platelet_count - PLATELET COUNT (phv00161385.v3.p3)
esp_sbp_baseline - BASELINE SYSTOLIC BLOOD PRESSURE (phv00161397.v3.p3)
esp_totchol_baseline - BASELINE TOTAL CHOLESTEROL (phv00165311.v2.p3)
esp_trigs_baseline - BASELINE TRIGLYCERIDES (phv00165312.v2.p3)
esp_wbc - WHITE BLOOD COUNT (phv00161379.v3.p3)
esp_wpw_at_ekg - WOLFF-PARKINSON-WHITE PATTERN (phv00165300.v2.p3)

Demographics (13)

ESP_AGE_AT_EKG - AGE AT EKG (phv00165303.v2.p3)
esp_age_at_factorvii - AGE AT FACTOR VII MEASUREMENT (phv00165305.v2.p3)
esp_age_at_fibrinogen - AGE AT FIBRINOGEN MEASUREMENT (phv00165307.v2.p3)
esp_age_at_hematocrit - AGE AT HEMATOCRIT MEASUREMENT (phv00161384.v3.p3)
esp_age_at_hemoglobin - AGE AT HEMOGLOBIN MEASUREMENT (phv00161382.v3.p3)
esp_age_at_platelet_count - AGE AT PLATELET COUNT (phv00161386.v3.p3)
esp_age_at_wbc - AGE AT WBC MEASUREMENT (phv00161380.v3.p3)
esp_age_baseline - AGE AT BASELINE WHI VARNAME=AGE (phv00161370.v3.p3)
esp_htn_status_baseline - BASELINE HYPERTENSION STATUS (phv00161399.v3.p3)
esp_sex - GENDER OF PARTICIPANT (phv00161367.v3.p3)
esp_stroke_baseline - BASELINE STROKE (phv00165272.v2.p3)
esp_stroke_during_followup - INCIDENT STROKE FROM STUDY ENROLLMENT (phv00165273.v2.p3)
esp_whr_baseline - BASELINE WAIST TO HIP RATIO (phv00165270.v2.p3)

Disease Events (11)

esp_angioplasty_baseline - BASELINE ANGIOPLASTY STATUS (phv00165286.v2.p3)
esp_angioplasty_during_followup - INCIDENT ANGIOPLASTY FROM STUDY ENROLLMENT (phv00165287.v2.p3)
esp_asthma_status_baseline - BASELINE ASTHMA STATUS (phv00165285.v2.p3)
esp_cabg_baseline - BASELINE CABG STATUS (phv00165289.v2.p3)
esp_cabg_during_followup - INCIDENT CABG FROM STUDY ENROLLMENT (phv00165290.v2.p3)
esp_mi_baseline - HISTORY OF MI AT BASEINE (phv00161371.v3.p3)
esp_mi_during_followup - INCIDENT MI FROM STUDY ENROLLMENT (phv00161372.v3.p3)
esp_pad_baseline - BASELINE PERIPHERAL ARTERY DISEASE STATUS (phv00165292.v2.p3)
esp_pad_during_followup - INCIDENT PAD FROM STUDY ENROLLMENT (phv00165293.v2.p3)
esp_stroke_famhx_baseline - BASELINE FAMILY HISTORY OF STROKE (phv00165276.v2.p3)
esp_t2diabetes_baseline - BASELINE TYPE TWO DIABETES STATUS (phv00161376.v3.p3)

Medications (3)

esp_htn_med_baseline - BASELINE HYPERTENSION MEDICATION (phv00161400.v3.p3)
esp_lipid_med_baseline - PARTICIPANT TAKING LIPID LOWERING MEDICATION BASELINE (phv00161378.v3.p3)
esp_t2d_med_baseline - BASELINE TYPE TWO DIABETES MEDICATION STATUS (phv00165267.v2.p3)

Race and Ethnicity (1)

esp_race - SELF REPORTED RACE OF PARTICIPANT (phv00161366.v3.p3)

Reproductive Health (3)

esp_age_at_menarche - AGE CATEGORIES FOR MENARCHE (phv00165281.v2.p3)
esp_age_at_menopause - AGE IN YEARS AT MENOPAUSE (phv00165280.v2.p3)
esp_menopause_status_baseline - BASELINE MENOPAUSE STATUS (phv00165279.v2.p3)

Substance Use (2)

esp_current_smoker_baseline - BASELINE CURRENT SMOKER (phv00165277.v2.p3)
esp_former_smoker_baseline - BASELINE FORMER SMOKER (phv00165278.v2.p3)

Other (21)

ANALYTE_TYPE - Analyte Type (phv00173957.v1.p3)
BODY_SITE - Body site where sample was collected (phv00173956.v1.p3)
DNA_EXTRACTION_METHOD - DNA extraction method (phv00173960.v1.p3)
duplicate_drop_info - Description of duplicate samples, tells the matching phenotype and sampleid (phv00165266.v2.p3)
esp_afib_tte_or_censor - TIME TO EVENT OR (phv00165284.v2.p3)
esp_angioplasty_tte_or_censor - NUMBER OF DAYS TO ANGIOPLASTY OR LAST CONTACT FROM BASELINE (phv00165288.v2.p3)
esp_cabg_tte_or_censor - NUMBER OF DAYS TO CABG OR LAST CONTACT FROM BASELINE (phv00165291.v2.p3)
esp_cohort - ESP STUDY (phv00161365.v3.p3)
esp_factorvii - FACTOR VII CONCENTRATION (phv00165304.v2.p3)
esp_fastglucose_baseline - BASELINE GLUCOSE (phv00165308.v2.p3)
esp_fibrinogen - FIBRINOGEN (phv00165306.v2.p3)
esp_frs_chdprob - ESTIMATED BASELINE FRS CHD PROBABILITY DERIVED (phv00161374.v3.p3)
esp_id - WHI ESP ID (phv00161364.v3.p3)
esp_inc_stroke_subtype - INCIDENT STROKE SUBTYPE (phv00165275.v2.p3)
esp_mi_tte_or_censor - NUMBER OF DAYS TO MI OR LAST CONTACT FROM BASELINE (phv00161373.v3.p3)
esp_pad_tte_or_censor - NUMBER OF DAYS FROM ENROLLMENT TO PAD OR CENSOR (phv00165294.v2.p3)
esp_phenotype - PHENOTYPE SAMPLE WAS SEQUENCED FOR (phv00161369.v3.p3)
esp_stroke_tte_or_censor - NUMBER OF DAYS TO STROKE OR LAST CONTACT FROM BASELINE (phv00165274.v2.p3)
HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00173958.v1.p3)
IS_TUMOR - Tumor status (phv00173959.v1.p3)
SAMPLEID - De-identified Sample ID (phv00173955.v1.p3)